How to Cite
Abstract
References
Anderson WF, Jatoi Sherman ME: Qualitative age Interactions in breast cancer studies: Mind the gap // J Clin Oncol. - 2009. - Vol. 27. - P. 5308-5311.
Beckmann KR, Buckingham J, Craft P et al. Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort // Breast. — 2011. — Vol. 20(2). — P. 158-164.
Bernstein JL, Lapinski RH, Thakore SS, et al: The descriptive epidemiology of second primary breast cancer // Epidemiology. — 2003. — Vol. 14. — P. 552-558.
Bertelsen L, Meilemkjaer L, Christensen J et al: Age-specific incidence of breast cancer in breast cancer survivors and their first-degree relatives // Epidemiology. — 2009. — Vol. 20. — P. 175-180.
Carmichael AR, Bendall S, Lockerbie L et al. The longterm outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours // Eur J Surg Oncol. — 2002. — Vol. 28(4). p. 388-91.
de la Rochefordiere A, Asselain B, Scholl S et al. Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases // Int J Radiat Oncol Biol Phys. — 1994. — Vol. 30(1). — P. 35-41.
Early Breast Cancer Trialists' Collaborative Group: Effects of chemotherapy and hormonal ^гару for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials // Lancet. — 2005. — Vol. 365. — P. 1687-1717.
Hartman M, Czene K, Reilly M et al. Genetic implications of bilateral breast cancer: a population based cohort study // Lancet Oncol. — 2005. — Vol. 6(6). — P. 377-382.
Hartman M, Czene K, Reilly Mf et al: Incidence and prognosis of synchronous and metachronous bilateral breast cancer // J Clin Oncol. — 2007. —Vol. 25. — P. 4210-4216.
Healey EA, Cook EF, Orav EJ et al: Contralateral breast cancer: Clinical characteristics and impact on prognosis. J Clin Oncol. — 1993. — Vol. 11. — P. 1545-1552.
Heron DE, Komarnicky LT, Hyslop T et al. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease // Cancer. — 2000. — Vol. 88(12). — P. 2739-2750.
Huo D, Melkonian S, Rathouz PJ et al. Concordance in histological and biological parameters between first and second primary breast cancers // Cancer. — 2011. — Vol. 117(5). — P. 907-915.
Intra M, Rotmensz N, Viale G et al. Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution // Cancer.- 2004. — Vol. 101(5). -P. 905-912.
Irvine T, Allen DS, Gillett C et al. Prognosis of synchronous bilateral breast cancer // Br J Surg. — 2009. — Vol. 96(4). — P. 376-380.
Jobsen JJ, van der Palen J, Ong F et al. Synchronous, bilateral breast cancer: prognostic value and incidence // Breast. — 2003. — Vol. 12(2). — P. 83-88.
Kheirelseid EA, Jumustafa H, Miller N et al. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics // Breast Cancer Res Treat. — 2010. — Vol. 126(l). — P. 131-140.
Kollias J, Ellis IO, Elston CW et al. Clinical and histological predictors of contralateral breast cancer // Eur J Surg Oncol. — 1999. — Vol. 25(6). — P. 584-589.
Kollias J, Ellis IO, Elston CW et al. Prognostic significance of synchronous and metachronous bilateral breast cancer // World J Surg. — 2001. — Vol. 25(9). — P. 1117-1124.
Levi F, Randimbison L, Te VC et al. Prognosis of bilateral synchronous breast cancer in Vaud, Switzerland // Breast. — 2003. — Vol. 12(2). — P. 89-91.
Mariotto A, Feuer EJ, Harlan LC et al: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999 // J Natl Cancer Inst. — 2002. — Vol. 94. — P. 1626-1634.
Marshall SF, Ziogas A, Castaneda J et al: Changing incidence of second primary breast cancer in California // Am J Epidemiol. — 2009. — P. 169:S4.
NATO: Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer: Interim analysis at four years by Nolvadex Adjuvant Trial Organisation // Lancet. — 1983. — Vol. 1. — P. 257-261.
Nichols H., Berrington de Gonzales A. Deckining incidence of contralateral breast cancer in the United States from 1975 to 2006 // J. Clin. Oncol. — 2011. — Vol. 29. — P. 1564-1569.
Olsson S, Andersson I, Karlberg I et al. Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme // J Med Screen. — 2000. — Vol. 7(l). — P. 14-18.
Peto J, Mack TM: High constant incidence in twins and other relatives of women with breast cancer // Nat Genet. — 2000. — Vol. 26. — P. 411-414.
Polednak AP. Bilateral synchronous breast cancer: a population-based study of characteristics, method of detection, and survival // Surgery. — 2003. — Vol. 133(4). — P. 383-389.
Renz DM, Bottcher J, Baltzer PA et al. The contralateral synchronous breast carcinoma: a comparison of histology, localization, and magnetic resonance imaging characteristics with the primary index cancer // Breast Cancer Res Treat. — 2010. —Vol. 120(2). — P. 449459.
Takahashi H, Watanabe K, Takahashi M et al. The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer //Breast Cancer. — 2005. — Vol. 12(3). — P. 196-202.
Vaittinen P, Hemminki K: Risk factors and age-incidence relationships for contralateral breast cancer // Int J Cancer. — 2000. — Vol. 88. — P. 998-1002.
Verkooijen HM, Chatelain V, Fioretta G et al. Survival after bilateral breast cancer: results from a population-based study // Breast Cancer Res Treat. — 2007. — Vol. 105(3). — P. 347-357.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...